Cancer Research The Future of Cancer Research: Science and Patient Impact  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 22, 361-367, April 1, 1962]
© 1962 American Association for Cancer Research

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Figard, P. H.
Right arrow Articles by Huang, D. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Figard, P. H.
Right arrow Articles by Huang, D. P.

The Phosphatides of Some Mouse Ascites Tumors and Rat Hepatomas*

Paul H. Figard, David M. Greenberg and Dolly P. Huang

( Department of Biochemistry, University of California School of Medicine, San Francisco, California)

An investigation of the phosphatide characteristics of certain experimental tumors yielded the following results.

The enzyme system for methylating phosphatidylaminoethanol to phosphatidylcholine was found to be largely lacking in mouse ascites tumors and rat hepatomas. Only in the Morris hepatoma was it present in amounts greater than 10 per cent of that in normal liver. The total phosphatide content of the tumors was much less than that in liver, largely owing to a lower total lipide content. The proportions of principal phosphatide components were not greatly altered in the tumor. Where there was a change, it was in the direction of increased cephalin and decreased lecithin, as compared with the level in normal tissue. The fatty acid patterns of the tumor lipides were not significantly different from those of the lipides of liver and blood cells.

* Aided by research grants from the American Cancer Society (T-88) and the Cancer Research Funds of the University of California.

Received 10/25/61.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1962 by the American Association for Cancer Research.